| Gene symbol | MIR34A | Synonyms | MIRN34A, miRNA34A, mir-34, mir-34a | Type of gene | ncRNA |
| Chromosome | 1 | Map location | 1p36.22|1p36.22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | microRNA 34a | ||||
| GTO ID | GTC0164 |
| Trial ID | NCT01829971 |
| Disease | Lung Non-Small Cell Carcinoma | Liver Cancer | Melanoma | Multiple Myeloma | Renal Cell Carcinoma | Lung Small Cell Carcinoma | Lymphoma |
| Altered gene | miR-34a |
| Therapeutic/Target gene | Target gene |
| Therapy | miRNA |
| Treatment | MRX34 |
| Co-treatment | dexamethasone (DEX) |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection |
| Year | 2013 |
| Country | Korea,Republic of|United States |
| Company sponsor | Mirna Therapeutics, Inc;Cancer Prevention Research Institute of Texas |
| Other ID(s) | MRX34-101 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||